News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Event
April 7, 2021
2021

SynBioBeta Biopharma Day 2021

Read article
News
April 5, 2021
2021

Published Peer-Reviewed Data Demonstrate Bamlanivimab’s High Potency Against SARS-CoV-2 and Support its Use as a Foundational Antibody Therapy to Treat and Prevent COVID-19

Read article
News
April 1, 2021
2021

AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration

Read article
Event
March 31, 2021
2021

US East Coast Antibody Therapeutics Xchange

Read article
Event
March 31, 2021
2021

Antibody Engineering & Therapeutics EU 2021

Read article
News
March 29, 2021
2021

AbCellera Reports Full Year 2020 Business Results

Read article
Event
March 11, 2021
2021

Biologics Europe: Online

Read article
Event
March 11, 2021
2021

PEGS Boston Virtual 2021

Read article
News
March 10, 2021
2021

AbCellera-Discovered Bamlanivimab Together with Etesevimab Reduced Hospitalizations and Prevented Death in Phase 3 Trial for Early COVID-19

Read article
News
March 5, 2021
2021

EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients

Read article